Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.

Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe. The firm was founded 1999 in New York, New York, United States, and is also known as Perceptive Xontogeny Venture Fund.

The firm is interested in companies that are industries of biotechnology and life sciences. The firm is interested in companies such as Sonendo, ArcherDX, Quellis Biosciences, Zentalis Pharmaceuticals, Avidity Biosciences, and Achilles Therapeutics. The firm invests during private equity and Series A rounds.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Kindbody
June 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- Kindbody, the leading fertility and family-building company, today announced it raised $62 million in Series C funding. The round was led by...
Bradley Saacks
May 12, 2021
Business Insider
Perceptive Advisors analyst Ellen Hukkelhoven presented at the annual Sohn Investment Conference on Wednesday.
BioSpace
May 12, 2021
BioSpace
Xontogeny LLC, a Boston-based accelerator that provides seed-stage investments along with strategic and operational support to early-stage life science companies, unveiled five of its latest portfolio companies.
Bradley Saacks
March 4, 2021
Business Insider
Adam Stone, chief investment officer of $8 billion Perceptive Advisors, told Insider that "I'd rather not do a deal than massively overpay."

References

Golden logo
By using this site, you agree to our Terms & Conditions.